FindTrial
Sign In

Role of Vasadi Kwath in the Management of Non Alcoholic Fatty Liver Disease A Clinical Study

Clinical study of Vasadi Kwath in the management of Non Alcoholic Fatty Liver Disease - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104474
Enrollment
60
Registered
2026-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Dr Debashree Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 18 to 60 years of age irrespective of the sex. 2. Patients having complaints of indigestion, pain abdomen, anorexia, fatigue, nausea and fulfilling the criteria of diagnosis. 3. Non alcoholic fatty liver- Grade I, Grade II and Grade III

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years more than 60 years. 2. Pregnancy and lactating mother. 3. Peptic ulcer. 4. Cancer patients. 5. Chronic Kidney Disease.

Design outcomes

Primary

MeasureTime frame
Decrease in symptoms of fatty liver after 15th, 30th, 45th day of taking medicineTimepoint: 15th day, 30th day, 45th day—

Secondary

MeasureTime frame
Decrease in symptoms Avipaka (Indigestion) , Angamarda (Bodyache) , Vaman (Vomiting) , Anaha (Distention), Dourbalya (Generalised Weakness) , Udarshool (Pain abdomen) , Aruchi (Loss of appetite) , Mandagni (Weak digestive system)Timepoint: 15th day, 30th day, 45th day—

Countries

India

Contacts

Public ContactDr Karab Ali

Govt Ayurvedic College and Hospital

dr.manir@gmail.com9864174788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026